New DNA test may help doctors spot lung cancer earlier from tiny biopsy samples
NCT ID NCT05415670
First seen Oct 31, 2025 · Last updated May 23, 2026 · Updated 22 times
Summary
This study tested a new method called whole-genome methylation sequencing (GM-seq) to improve how doctors tell if a lung nodule is cancerous or not. Researchers collected small tissue samples from 158 people during bronchoscopy and compared the new DNA-based test with standard pathology. The goal was to see if GM-seq could more accurately diagnose malignant nodules, using surgical results as the final answer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY NODULE, SOLITARY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing hospital
Beijing, Beijing Municipality, 100730, China
-
Emergency general hospital
Beijing, Beijing Municipality, 100028, China
Conditions
Explore the condition pages connected to this study.